Induction of apoptosis by homoharringtonine in G1 phase human chronic myeloid leukemic cells

Chinese Medical Journal

Volumn 118, Issue 6, 2005, Pages 487-492

  Mai, Wen Yuan ^a   Lin, Mao Fang ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Apoptosis; Cell cycle; Homoharringtonine; Leukemic cell

Indexed keywords

CEPHALOTAXINE; CYCLOHEXIMIDE; DACTINOMYCIN; HOMOHARRINGTONINE;

AGAR GEL ELECTROPHORESIS; APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL NUCLEUS MEMBRANE; CHROMATIN CONDENSATION; CHRONIC MYELOID LEUKEMIA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EXPOSURE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL; NICK END LABELING; PROTEIN SYNTHESIS; RNA TRANSCRIPTION; TRANSMISSION ELECTRON MICROSCOPY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CYCLOHEXIMIDE; DACTINOMYCIN; G1 PHASE; HARRINGTONINES; HUMANS; K562 CELLS; LEUKEMIA, MYELOID, CHRONIC;

EID: 16344369386     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Cephalotaxus Research Coordinating Group. Cephalotaxine esters in the treatment of acute leukemia. A preliminary clinical assessment. Chin Med J 1976;2:263-272.
2. Wu DP, Wu XJ, Shi PM, et al. Clinical study of a new protocal for patients with relapsed or refractory AML. Chin J Hematol (Chin) 2004;25:51-52.
3. Degos LK. The history of acute promyelocytic leukemia. Br J Haematol 2003;122:539-553.
4. Hehlmann R, Hochhaus A, Berger U, et al. Current trends in the management of chronic myelogenous leukemia. Ann Hematol 2000;79:345-354.
5. Huang MT. Harringtonine, an inhibitor of initiation of protein biosynthesis. Mol Pharmacol 1975; 11: 511-519.
6. Fresno M, Jimenez A, Vazqueq D. Inhibition of translation in eukaryotic systems by harringtonine. Eur J Biochem 1977;72;323-330.
7. Wang Y, Sun GL, Wu WL, et al. Experimental study: apoptosis and differentiation on K562 and CML cells induced by homoharringtonine. Shanghai Med J (Chin) 2001;24:166-168.
8. Ye XJ, Lin MF. Homoharringtonine induces apoptosis of endothlium and down-regulates VEGF expression of K562 cells. J Zhejiang Univ Sci 2004;5:230-234.
9. Skladanowski A, Konopa J. Adriamycin and daunomycin induce programmed cell death (apoptosis) in tumor cells. Biochem Pharmacol 1993;46:375-382.
10. Gavrieli Y, Sherman Y, Ben-Sasson S, et al. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
11. Jacysyn JF, Conde MM, Barrichello CR, et al. Thymic epithelial cells mediate a Bcl-2-independent protection of single-positive thymocytes from dexamethasone-induced apoptosis. Exp Cell Res 2002;272:119-126.
12. Ormerod MG, Orr RM, Peacock JH. The role of apoptosis in cell killing by cisplatin: a flow cytometric study. Br J Cancer 1994;69:93-100.
13. Vaux DL, Strasser A. The molecular biology of apoptosis. Proc Natl Acad Sci U S A 1996;93:2239-2241.
14. Zaldumbide A, Carlotu F, Pognonec P, et al. The role of Ets2 transcription factor in the proliferation, maturation, and survival of mouse thymocytes. J Immunol 2002;169:4873-4881.
15. Kwon SH,Ahn SH, Kim YK ,et al. Apicidin, a histone deacetylase inhibitor, induces apoptosis and Fas/Fas ligand expression in human acute promyelocytic leukemia cells. J Biol Chem 2002;277:2073-2080.
16. Takahashi K, Inanami O, Hayashi M, et al. Protein synthesis-dependent apoptosis signaling pathway in X-irradiated MOLT-4 human leukaemia cell line. Int J Radiat Biol 2002;78:115-124.
17. Lu Y, Zhou R, Zhang S, et al. The cellular and molecular mechanism of lamin-glycopeptides on anti-metastasis. Chin Med J 2000;113:466-470.